Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions.
Prions are unconventional infectious agents composed exclusively of misfolded prion protein (PrP(Sc)), which transmits the disease by propagating its abnormal conformation to the cellular prion protein (PrP(C)). A key characteristic of prions is their species barrier, by which prions from one species can only infect a limited number of other species. Here, we report the generation of infectious prions by interspecies transmission of PrP(Sc) misfolding by in vitro PMCA amplification. Hamster PrP(C) misfolded by mixing with mouse PrP(Sc) generated unique prions that were infectious to wild-type hamsters, and similar results were obtained in the opposite direction. Successive rounds of PMCA amplification result in adaptation of the in vitro-produced prions, in a process reminiscent of strain stabilization observed upon serial passage in vivo. Our results indicate that PMCA is a valuable tool for the investigation of cross-species transmission and suggest that species barrier and strain generation are determined by the propagation of PrP misfolding.
Castilla
Joaquín
J
Department of Neurology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Gonzalez-Romero
Dennisse
D
Saá
Paula
P
Morales
Rodrigo
R
De Castro
Jorge
J
Soto
Claudio
C
D000818:Animals; D001921:Brain / Q000473:pathology; D002474:Cell-Free System; D006224:Cricetinae; D051379:Mice; D018620:PrPSc Proteins / Q000378:metabolism*; D017096:Prion Diseases / Q000473:pathology / Q000635:transmission*; D011328:Prions / Q000378:metabolism*; D017510:Protein Folding; D013045:Species Specificity
D018620:PrPSc Proteins; D011328:Prions
J Neurosci Methods. 2007 Sep 30;165(2):183-90
17644183
J Virol. 2007 Sep;81(17):9605-8
17553879
Ciba Found Symp. 1988;135:37-62
3137002
Vet Rec. 1993 Oct 2;133(14):339-41
8236676
Cell. 2005 Apr 8;121(1):49-62
15820678
Nature. 2004 Mar 18;428(6980):323-8
15029196
Nature. 1996 Oct 24;383(6602):685-90
8878476
Arch Virol Suppl. 2005;(19):187-202
16355873
Science. 1982 Apr 9;216(4542):136-44
6801762
Berl Munch Tierarztl Wochenschr. 2005 Sep-Oct;118(9-10):365-71
16206923
Nature. 2004 Mar 18;428(6980):319-23
15029195
J Gen Virol. 1989 Aug;70 ( Pt 8):2017-25
2504883
Acta Vet Scand Suppl. 2003;98:33-42
15259778
J Virol. 2001 Nov;75(21):10106-12
11581378
Cell. 2005 Apr 22;121(2):195-206
15851027
Mol Cell. 2004 Apr 9;14(1):139-45
15068810
Yeast. 1995 Dec;11(16):1671-85
8720070
Trends Neurosci. 2002 Aug;25(8):390-4
12127750
Contrib Microbiol. 2004;11:33-49
15077403
Lancet. 1999 Jul 24;354(9175):317-23
10440324
Annu Rev Neurosci. 2001;24:519-50
11283320
Nature. 2001 Jun 14;411(6839):810-3
11459061
Br Med Bull. 2003;66:99-108
14522852
Vet Microbiol. 2007 Aug 31;123(4):346-57
17493773
EMBO J. 2005 Sep 7;24(17):3082-92
16096644
Nat Methods. 2007 Aug;4(8):645-50
17643109
J Pathol. 2007 Sep;213(1):21-6
17614097
Biochim Biophys Acta. 2007 Jun;1772(6):681-91
17254754
Vet Pathol. 2005 Sep;42(5):530-49
16145200
Nat Med. 2000 Mar;6(3):258-9
10700223
J Biol Chem. 2006 Feb 17;281(7):4199-206
16338930
Neurosci Lett. 2007 Feb 21;413(3):270-3
17174030
Curr Top Microbiol Immunol. 2004;284:133-59
15148991
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83
9811807
Br Med Bull. 2003;66:171-83
14522858
Mol Biotechnol. 1998 Jun;9(3):225-34
9718582
Nat Med. 2004 Jul;10 Suppl:S63-7
15272271
Neuron. 2002 Jun 13;34(6):854-6
12086631
Nat Med. 1998 Oct;4(10):1157-65
9771749
J Biol Chem. 2005 Jul 22;280(29):26873-9
15917229
J Biochem Biophys Methods. 2005 Jun 30;63(3):213-21
15967508
Arch Virol Suppl. 2000;(16):209-16
11214924
FEBS Lett. 2005 Jan 31;579(3):638-42
15670821
Biochim Biophys Acta. 2007 Jun;1772(6):610-8
17223321
Methods Mol Biol. 2005;299:53-65
15980595
J Infect Dis. 2002 Dec 1;186 Suppl 2:S166-70
12424693
Methods Enzymol. 2006;412:3-21
17046648
CNS Drugs. 2006;20(1):15-28
16396521
Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9741-6
17535913
Lancet. 1996 Apr 6;347(9006):921-5
8598754